Allspring Global Investments
TBPH icon

Allspring Global Investments’s Theravance Biopharma TBPH Stock Holding History

Allspring Global Investments’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Buy
+10,783
New +$191K ﹤0.01% 1622
2024
Q4 		– Sell
-521
Closed -$4.2K – 2358
2024
Q3 		$4.2K Buy
+521
New +$4.51K ﹤0.01% 2203
2023
Q2 		– Sell
-7,631
Closed -$82.8K – 2833
2023
Q1 		$82.8K Sell
7,631
-7,720
-50% -$81.6K ﹤0.01% 2117
2022
Q4 		$172K Sell
15,351
-5,282
-26% -$55.5K ﹤0.01% 1869
2022
Q3 		$209K Buy
20,633
+2,547
+14% +$23.9K ﹤0.01% 1802
2022
Q2 		$163K Buy
18,086
+6,942
+62% +$64K ﹤0.01% 1883
2022
Q1 		$106K Buy
+11,144
New +$109K ﹤0.01% 2740

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return